CVR: 40337326
Betamab ApS was a Danish company of the type Anpartsselskab based in Humlebæk, founded in 2019 and dissolved in 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK -736,481 and a net result of DKK -1,363,690. Equity amounted to DKK 418,926.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreScreen owners and management against the Danish FSA's official PEP lists
As of May 17, 2022, 18. juni 2024 P/S has stepped down as auditor of Betamab ApS.
As of May 17, 2022, Preben Meldgaard has stepped down as liquidator of Betamab ApS.
On May 17, 2022, Betamab ApS exited liquidation.
Betamab ApS was dissolved on May 17, 2022.
As of October 5, 2021, Søren Mouritsen has left the board of directors of Betamab ApS.
As of October 5, 2021, Morten Peter Meldal has left the board of directors of Betamab ApS.
As of October 5, 2021, Preben Meldgaard is registered as liquidator of Betamab ApS.
As of October 5, 2021, Søren Mouritsen has stepped down as adm. dir. of Betamab ApS.
As of October 5, 2021, Teit Eliot Johansen has stepped down as chairman of Betamab ApS.
As of October 5, 2021, Morten Peter Meldal has stepped down as director of Betamab ApS.
On October 5, 2021, Betamab ApS entered liquidation.
Betamab ApS has published its annual report for 2020. Gross profit came to DKK -736,481, and the net result was DKK -1,363,690.
Betamab ApS has published its interim report for the period March 11, 2019 – December 31, 2019.
As of June 30, 2020, 18. juni 2024 P/S has been appointed auditor of Betamab ApS.
As of March 31, 2020, Søren Mouritsen has joined the board of directors of Betamab ApS.
As of March 31, 2020, Morten Peter Meldal has joined the board of directors of Betamab ApS.
As of March 31, 2020, Teit Eliot Johansen is registered as chairman of Betamab ApS.
As of March 11, 2019, Søren Mouritsen is registered as adm. dir. of Betamab ApS.
As of March 11, 2019, Morten Peter Meldal is registered as director of Betamab ApS.
Betamab ApS was founded on March 11, 2019.
companydata.dk